Guardant Health Form 4: Insider Adds Shares, Sells for Taxes
Rhea-AI Filing Summary
Form 4 highlights for Guardant Health, Inc. (GH): Co-Chief Executive Officer and Director Helmy Eltoukhy reported two routine RSU vesting events and related tax-withholding sales over 30 June-1 July 2025.
- RSU vesting (Code “M”): 4,815 shares vested on 30 Jun 2025 and 23,997 shares vested on 1 Jul 2025, totalling 28,812 shares acquired at $0 exercise price.
- Tax withholding sales (Code “F”): 2,441 shares sold at $52.04 and 12,162 shares sold at $50.71 to cover payroll taxes, for an aggregate 14,603 shares disposed.
- Net change: Insider’s direct common-stock position rose by 14,209 shares, bringing total direct ownership to 2,423,499 shares. He also continues to hold 143,983 unvested RSUs.
- Derivative section clarifies the vesting schedules: a 4-installment 2025 grant and a previously granted award that vests quarterly over 24 months.
All transactions are routine equity-compensation events; no open-market purchases or discretionary sales were reported. The filing signals ongoing insider equity accumulation and substantial alignment, but does not reveal new operational or financial information about Guardant Health.
Positive
- Net insider accumulation: CEO’s direct holdings increased by 14,209 shares, reflecting continued equity alignment with shareholders.
- Significant ownership: Post-transaction stake stands at 2,423,499 shares plus 143,983 RSUs, suggesting long-term commitment.
Negative
- None.
Insights
TL;DR Routine RSU vesting; CEO nets 14k shares, maintains 2.4 M stake—neutral fundamental impact, slight positive sentiment.
The Form 4 shows standard compensation mechanics: RSUs from 2025 grants vested and were converted into common shares. Mandatory sell-to-cover transactions removed 14,603 shares at prevailing market prices (~$51 average), leaving a net gain of 14,209 shares. The insider now owns more than 2.4 million shares plus 144 k RSUs, underscoring sizeable exposure to Guardant’s equity performance. Because sales were solely for tax obligations and no discretionary selling occurred, the signal is neutral-to-slightly positive—it indicates commitment but offers no new insight into company fundamentals. From a portfolio perspective, the activity is not material to valuation or near-term catalyst tracking.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | $0.00 |
| Exercise | Common Stock | 23,997 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 12,162 | $50.71 | $617K |
| Exercise | Restricted Stock Units | 4,815 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,815 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,441 | $52.04 | $127K |
Footnotes (4)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
- F3. Not applicable for Restricted Stock Units.
- F4. This restricted stock unit award vested with respect to 1/3 of the shares on January 1, 2025. The remaining shares vest quarterly for the remaining twenty-four months.
AI-generated analysis. How Rhea-AI works. Not financial advice.
